|Free Dividend Report|
|Stock Splits Calendar|
|LIFE Stock Split History|
|Preferred Stock Newsletter|
|LIFE Options Chain|
|LIFE Message Board|
aTyr Pharma (LIFE) has 3 splits in our LIFE split history database. The first split for LIFE took place on July 16, 1991. This was a 3 for 2 split, meaning for each 2 shares of LIFE owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 1500 share position following the split. LIFE's second split took place on December 18, 2003. This was a 2 for 1 split, meaning for each share of LIFE owned pre-split, the shareholder now owned 2 shares. For example, a 1500 share position pre-split, became a 3000 share position following the split. LIFE's third split took place on July 01, 2019. This was a 1 for 14 reverse split, meaning for each 14 shares of LIFE owned pre-split, the shareholder now owned 1 share. For example, a 3000 share position pre-split, became a 214.285714285714 share position following the split.
When a company such as aTyr Pharma splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business. When a company such as aTyr Pharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the LIFE split history from start to finish, an original position size of 1000 shares would have turned into 214.285714285714 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into aTyr Pharma shares, starting with a $10,000 purchase of LIFE, presented on a split-history-adjusted basis factoring in the complete LIFE split history.
Growth of $10,000.00
Without Dividends Reinvested
|Average Annual Total Return:||-42.51%|
|About aTyr Pharma|
|aTyr Pharma is a biotherapeutics company engaged in the discovery and clinical development of medicines based on immunological pathways. Within its synthetase platform, Co. is primarily focused on the therapeutic translation of the Resokine pathway, comprised of extracellular proteins derived from the histidyl tRNA synthetase (HARS) gene family. Co.'s clinical stage product candidate, ATYR1923, is a fusion protein comprised of the immuno-modulatory domain of HARS fused to the FC region of a human antibody. ATYR1923 is also a selective modulator of Neuropilin-2 that downregulates the innate and adaptive immune response in inflammatory disease states. According to our LIFE split history records, aTyr Pharma has had 3 splits.|
|LIFE Split History Table|
|07/16/1991||3 for 2|
|12/18/2003||2 for 1|
|07/01/2019||1 for 14|
|Healthcare Stock Splits|
|LIFE is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
Also explore: LIFE shares outstanding history